Given the importance of balanced BCL2 and BIM protein levels for controlling normal B cell survival and suppressing B cell lymphoma [1], it would not be surprising that BCL2 protein turnover be governed by multiple, redundant ubiquitin ligases. The gene discussed is BCL2L11; the disease is B-cell non-Hodgkin lymphoma.